Patents Examined by Nashaat T. Nasheed
  • Nuclear inhibitor I-92 and its use for the production of a medicament
    Patent number: 6045831
    Abstract: The present invention concerns a nuclear inhibitor which specifically inhibits the activity of sequence specific DNA enhancer binding proteins of Human Papilloma Virus (HPV) and the use of this nuclear inhibitor for the production of a medicament for treatment of human cervical cancer.
    Type: Grant
    Filed: January 19, 1994
    Date of Patent: April 4, 2000
    Assignee: Dade Behring Marburg GmbH
    Inventors: Jurgen Weitz, Hans-Dieter Royer, Michael Stohr, Marijana Kopun, Inge Napierski
  • Methods and compositions for enhancing erythromycin production
    Patent number: 5976836
    Abstract: The present invention provides isolated and purified polypeptides that increase antibiotic production, polynucleotides that encode those polypeptides, expression vectors containing those polynucleotides, host cells transformed with those expression vectors, a process of making the polypeptides using those polynucleotides and vectors, and processes using those polypeptides and polynucleotides.
    Type: Grant
    Filed: May 7, 1997
    Date of Patent: November 2, 1999
    Assignee: FermaLogic, Inc.
    Inventors: J. Mark Weber, Paul E. Hessler, Peter E. Larsen, Minh B. Luu
  • Human glycosyltransferase gene, compounds and method for inhibiting cancerous metastasis
    Patent number: 5874271
    Abstract: A gene encoding human glycosyltransferase (human GnT-III) and recombinant DNA method for producing the enzyme are provided. A cancerous metastasis inhibitor comprising GnT-III, or a gene thereof, and a method of inhibiting cancerous metastasis in a mammal are also provided.
    Type: Grant
    Filed: September 7, 1995
    Date of Patent: February 23, 1999
    Assignee: Takara Shuzo Co., Ltd.
    Inventors: Atsushi Nishikawa, Yoshito Ihara, Masafumi Yoshimura, Shunichiro Taniguchi, Naoyuki Taniguchi